Sang Mi Lee provides insights on the The Way Ahead for Cell and Gene Therapies at the Canadian Institute 9th Annual Forum: Pathways To Access & Reimbursement February 13, 2024.
Last week, MORSE Consulting Inc.’s Sang Mi Lee delivered a presentation at the 2024 Canadian Institute’s Pathways to Access & Reimbursement Conference in Toronto. Conference attendees found Sang Mi’s presentation on opportunities and challenges associated with cell and gene therapies in the Canadian health system very insightful. We are inspired by the passionate community and hope this talk contributes to the conversation on how all stakeholders can collaborate to support sustainable access and implementation of cell and gene therapies in Canada.
We would like to thank Patrick Bedford for providing fundamental regulatory insights and valuable contributions to our presentation.
Download our presentation to learn more about “The Way Ahead for Cell and Gene Therapies: How to Create Healthcare System Infrastructure that Supports New Pathways to Access and Reimbursement”:
To receive updates similar to this one please be sure to sign up for MORSE Signals, our free e-mail newsletter service.
